Capital raised by Entact Bio
1 Form D filing · first filed Jan 2026 · Watertown, MA
Chief Executive Officer and Director of the Issuer
Signatory on Entact Bio's Form D filings · $10.0M raised across 1
Victoria Richon is on file as Chief Executive Officer and Director of the Issuer at Entact Bio in Watertown, MA. Entact Bio has 1 Form D filing on record, $10.0M raised in total. Victoria Richon appears as a signatory on the company's filings.
LinkedIn profileA discovery and optimization platform for ENTAC medicines - bifunctional small molecules that bring a target protein together with a deubiquitylase so the DUB's natural activity enhances that protein's function. The platform systematically tests DUB-substrate combinations to inform rational ENTAC design.
